Citation: | Fengzhen Wang, Mingwan Zhang, Dongsheng Zhang, Yuan Huang, Li Chen, Sunmin Jiang, Kun Shi, Rui Li. Preparation, optimization, and characterization of chitosancoated solid lipid nanoparticles for ocular drug delivery[J]. The Journal of Biomedical Research, 2018, 32(6): 411-423. DOI: 10.7555/JBR.32.20160170 |
[1] | Tiwari-Heckler Shilpa, Jiang Z. Gordon, Popov Yury, J. Mukamal Kenneth. Daily high-dose aspirin does not lower APRI in the Aspirin-Myocardial Infarction Study[J]. The Journal of Biomedical Research, 2020, 34(2): 139-142. DOI: 10.7555/JBR.33.20190041 |
[2] | Tao Chun'ai, Gan Yongxin, Su Weidong, Li Zhutian, Tang Xiaolan. Effectiveness of hospital disinfection and experience learnt from 11 years of surveillance[J]. The Journal of Biomedical Research, 2019, 33(6): 408-413. DOI: 10.7555/JBR.33.20180118 |
[3] | Huan Liu, Shijiang Zhang, Yongfeng Shao, Xiaohu Lu, Weidong Gu, Buqing Ni, Qun Gu, Junjie Du. Biomechanical characterization of a novel ring connector for sutureless aortic anastomosis[J]. The Journal of Biomedical Research, 2018, 32(6): 454-460. DOI: 10.7555/JBR.31.20170011 |
[4] | Minbo Zang, Qiao Zhou, Yunfei Zhu, Mingxi Liu, Zuomin Zhou. Effects of chemotherapeutic agent bendamustine for nonhodgkin lymphoma on spermatogenesis in mice[J]. The Journal of Biomedical Research, 2018, 32(6): 442-453. DOI: 10.7555/JBR.31.20170023 |
[5] | Kaibo Lin, Shikun Zhang, Jieli Chen, Ding Yang, Mengyi Zhu, Eugene Yujun Xu. Generation and functional characterization of a conditional Pumilio2 null allele[J]. The Journal of Biomedical Research, 2018, 32(6): 434-441. DOI: 10.7555/JBR.32.20170117 |
[6] | Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065 |
[7] | Christopher J. Danford, Zemin Yao, Z. Gordon Jiang. Non-alcoholic fatty liver disease: a narrative review of genetics[J]. The Journal of Biomedical Research, 2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045 |
[8] | Shaymaa Elsaka, Amr Elnaghy. Effect of addition of chitosan to self-etching primer: antibacterial activity and push-out bond strength to radicular dentin[J]. The Journal of Biomedical Research, 2012, 26(4): 288-294. DOI: 10.7555/JBR.26.20120042 |
[9] | Shaymaa Elsayed Elsaka, Amr Mohamed Elnaghy. Antibacterial activity of calcium hydroxide combined with chitosan solutions and the outcomes on the bond strength of RealSeal sealer to radicular dentin[J]. The Journal of Biomedical Research, 2012, 26(3): 193-195. DOI: 10.7555/JBR.26.20110136 |
[10] | Sundeep?S.?Tumber, Hong?Liu. Epidural abscess after multiple lumbar punctures for labour epidural catheter placement[J]. The Journal of Biomedical Research, 2010, 24(4): 332-335. DOI: 10.1016/S1674-8301(10)60046-2 |
1. | Najib Ullah SNM, Afzal O, Altamimi ASA, et al. Bedaquiline-Loaded Solid Lipid Nanoparticles Drug Delivery in the Management of Non-Small-Cell Lung Cancer (NSCLC). Pharmaceuticals (Basel), 2023, 16(9): 1309. DOI:10.3390/ph16091309 |
2. | Amrutkar CS, Patil SB. Nanocarriers for ocular drug delivery: Recent advances and future opportunities. Indian J Ophthalmol, 2023, 71(6): 2355-2366. DOI:10.4103/ijo.IJO_1893_22 |
3. | Gugleva V, Andonova V. Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms. Pharmaceuticals (Basel), 2023, 16(3): 474. DOI:10.3390/ph16030474 |
4. | Albarqi HA, Garg A, Ahmad MZ, et al. Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma. Pharmaceutics, 2023, 15(2): 681. DOI:10.3390/pharmaceutics15020681 |
5. | Shawky S, Makled S, Awaad A, et al. Quercetin Loaded Cationic Solid Lipid Nanoparticles in a Mucoadhesive In Situ Gel-A Novel Intravesical Therapy Tackling Bladder Cancer. Pharmaceutics, 2022, 14(11): 2527. DOI:10.3390/pharmaceutics14112527 |
6. | Wang J, Wang H, Xu H, et al. Solid lipid nanoparticles as an effective sodium aescinate delivery system: formulation and anti-inflammatory activity. RSC Adv, 2022, 12(11): 6583-6591. DOI:10.1039/d1ra07638h |
7. | Bonilla L, Espina M, Severino P, et al. Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics, 2021, 14(1): 90. DOI:10.3390/pharmaceutics14010090 |
8. | Yu Z, Ding W, Aleem MT, et al. Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant. Pharmaceutics, 2021, 13(5): 752. DOI:10.3390/pharmaceutics13050752 |
9. | González-Fernández FM, Bianchera A, Gasco P, et al. Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation. Pharmaceutics, 2021, 13(4): 447. DOI:10.3390/pharmaceutics13040447 |
10. | Gorantla S, Rapalli VK, Waghule T, et al. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv, 2020, 10(46): 27835-27855. DOI:10.1039/d0ra04971a |
11. | Chrissian C, Lin CP, Camacho E, et al. Unconventional Constituents and Shared Molecular Architecture of the Melanized Cell Wall of C. neoformans and Spore Wall of S. cerevisiae. J Fungi (Basel), 2020, 6(4): 329. DOI:10.3390/jof6040329 |
12. | Mahmood S, Kiong KC, Tham CS, et al. PEGylated Lipid Polymeric Nanoparticle-Encapsulated Acyclovir for In Vitro Controlled Release and Ex Vivo Gut Sac Permeation. AAPS PharmSciTech, 2020, 21(7): 285. DOI:10.1208/s12249-020-01810-0 |
13. | Zamboulis A, Nanaki S, Michailidou G, et al. Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments. Polymers (Basel), 2020, 12(7): 1519. DOI:10.3390/polym12071519 |
14. | Jumelle C, Gholizadeh S, Annabi N, et al. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release, 2020, 321: 1-22. DOI:10.1016/j.jconrel.2020.01.057 |